Genome Editing Should Preferably Be Carried Out on Fetuses In Utero Rather Than IVF Embryos
- PMID: 40304838
 - DOI: 10.1007/s11673-024-10415-2
 
Genome Editing Should Preferably Be Carried Out on Fetuses In Utero Rather Than IVF Embryos
Keywords: Defect; Ethics; Fetal; Gene therapy; Monogenic disorders; Preimplantation embryo.
Conflict of interest statement
Declarations. Ethical Declaration: No human subjects or laboratory animals were utilized. Conflict of Interests: None.
References
- 
    
- Khan, S., and K. Drabiak. 2024. Eight strategies to engineer acceptance of human germline modifications. Journal of Bioethical Inquiry 21(1): 81–94. - PubMed
 
 - 
    
- Kubikova, N., M. Esbert, S. Titus, et al. 2023. Deficiency of DNA double-strand break repair in human preimplantation embryos revealed by CRISPR-Cas9. Human Reproduction 38(S1): dead093.089.
 
 - 
    
- Liang, P., Y. Xu, X. Zhang, et al. 2015. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein & Cell 6(5): 363–372.
 
 - 
    
- Madero, J.I., M.C. Manotas, M. García-Acero, A. López Cáceres, and J.C. López. 2023. Preimplantation genetic testing in assisted reproduction. Minerva Obstetrics and Gynecology 75(3): 260–272. - PubMed
 
 - 
    
- Mattar, C.N.Z., M.K. Labude, T.N. Lee, and P.S. Lai. 2021. Ethical considerations of preconception and prenatal gene modification in the embryo and fetus. Human Reproduction 36(12): 3018–3027. - PubMed
 
 
LinkOut - more resources
Full Text Sources
